Tumor microenvironment-mediated immune tolerance in development and treatment of gastric cancer

被引:75
|
作者
Liu, Yuanda [1 ]
Li, Changfeng [1 ]
Lu, Yaoping [2 ]
Liu, Chang [1 ]
Yang, Wei [2 ]
机构
[1] Jilin Univ, Dept Endoscopy Ctr, China Japan Union Hosp, Changchun, Peoples R China
[2] Jilin Univ, Coll Basic Med Sci, Dept Immunol, Changchun, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷
关键词
immune tolerance; tumor microenvironment; gastric cancer; immunotherapy; tumor-infiltrating immune cells; EPITHELIAL-MESENCHYMAL TRANSITION; NATURAL-KILLER-CELLS; T-CELLS; GASTROESOPHAGEAL JUNCTION; PATHOLOGICAL FUNCTIONS; M2; POLARIZATION; PROMOTES; MACROPHAGES; FIBROBLASTS; ACTIVATION;
D O I
10.3389/fimmu.2022.1016817
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Tumor microenvironment is the general term for all non-cancer components and their metabolites in tumor tissue. These components include the extracellular matrix, fibroblasts, immune cells, and endothelial cells. In the early stages of tumors, the tumor microenvironment has a tumor suppressor function. As the tumor progresses, tumor immune tolerance is induced under the action of various factors, such that the tumor suppressor microenvironment is continuously transformed into a tumor-promoting microenvironment, which promotes tumor immune escape. Eventually, tumor cells manifest the characteristics of malignant proliferation, invasion, metastasis, and drug resistance. In recent years, stress effects of the extracellular matrix, metabolic and phenotypic changes of innate immune cells (such as neutrophils, mast cells), and adaptive immune cells in the tumor microenvironment have been revealed to mediate the emerging mechanisms of immune tolerance, providing us with a large number of emerging therapeutic targets to relieve tumor immune tolerance. Gastric cancer is one of the most common digestive tract malignancies worldwide, whose mortality rate remains high. According to latest guidelines, the first-line chemotherapy of advanced gastric cancer is the traditional platinum and fluorouracil therapy, while immunotherapy for gastric cancer is extremely limited, including only Human epidermal growth factor receptor 2 (HER-2) and programmed death ligand 1 (PD-L1) targeted drugs, whose benefits are limited. Clinical experiments confirmed that cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), vascular endothelial growth factor receptor (VEGFR) and other targeted drugs alone or in combination with other drugs have limited efficacy in patients with advanced gastric cancer, far less than in lung cancer, colon cancer, and other tumors. The failure of immunotherapy is mainly related to the induction of immune tolerance in the tumor microenvironment of gastric cancer. Therefore, solving the immune tolerance of tumors is key to the success of gastric cancer immunotherapy. In this study, we summarize the latest mechanisms of various components of the tumor microenvironment in gastric cancer for inducing immune tolerance and promoting the formation of the malignant phenotype of gastric cancer, as well as the research progress of targeting the tumor microenvironment to overcome immune tolerance in the treatment of gastric cancer.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] Systemic inflammation is associated with the density of immune cells in the tumor microenvironment of gastric cancer
    Yeonjoo Choi
    Jin Won Kim
    Kyung Han Nam
    Song-Hee Han
    Ji-Won Kim
    Sang-Hoon Ahn
    Do Joong Park
    Keun-Wook Lee
    Hye Seung Lee
    Hyung-Ho Kim
    Gastric Cancer, 2017, 20 : 602 - 611
  • [32] Systemic inflammation is associated with the density of immune cells in the tumor microenvironment of gastric cancer
    Choi, Y.
    Kim, J. W.
    Nam, K. H.
    Kim, J-W.
    Ahn, S-H.
    Park, D. J.
    Lee, K-W.
    Lee, H. S.
    Kim, H-H.
    ANNALS OF ONCOLOGY, 2016, 27
  • [33] Characterization of glycometabolism and tumor immune microenvironment for predicting clinical outcomes in gastric cancer
    Shi, Jinyao
    Wu, Zhouqiao
    Wu, Xiaolong
    Huangfu, Longtao
    Guo, Ting
    Cheng, Xiaojing
    Han, Jing
    Li, Ziyu
    Xing, Xiaofang
    Ji, Jiafu
    ISCIENCE, 2023, 26 (03)
  • [34] Integrated bioinformatics analysis of noncoding RNAs with tumor immune microenvironment in gastric cancer
    Xu, Jun
    Hu, Shengnan
    Chen, Qiuli
    Shu, Lilu
    Wang, Peter
    Wang, Jianjiang
    SCIENTIFIC REPORTS, 2023, 13 (01):
  • [35] Prognostic molecular subtype reveals the heterogeneity of tumor immune microenvironment in gastric cancer
    Hui Dai
    Jing Ren
    Chun Wang
    Jianfei Huang
    Xudong Wang
    Scientific Reports, 15 (1)
  • [36] Integrated bioinformatics analysis of noncoding RNAs with tumor immune microenvironment in gastric cancer
    Jun Xu
    Shengnan Hu
    Qiuli Chen
    Lilu Shu
    Peter Wang
    Jianjiang Wang
    Scientific Reports, 13 (1)
  • [37] Noninvasive imaging evaluation of tumor immune microenvironment to predict outcomes in gastric cancer
    Jiang, Y.
    Wang, H.
    Wu, J.
    Chen, C.
    Yuan, Q.
    Huang, W.
    Li, T.
    Xi, S.
    Hu, Y.
    Zhou, Z.
    Xu, Y.
    Li, G.
    Li, R.
    ANNALS OF ONCOLOGY, 2020, 31 (06) : 760 - 768
  • [38] Identification of Gastric Cancer Immune Microenvironment Related Genes with Poor Prognosis and Tumor Immune Infiltration
    Wang, Yishu
    Xu, Lingyun
    Tian, Xuehan
    Lin, Zhe
    BIOINFORMATICS RESEARCH AND APPLICATIONS, ISBRA 2021, 2021, 13064 : 142 - 152
  • [39] Tumor Immune Microenvironment and Chemosensitivity Signature for Predicting Response to Chemotherapy in Gastric Cancer
    Jiang, Yuming
    Xie, Jingjing
    Huang, Weicai
    Chen, Hao
    Xi, Sujuan
    Han, Zhen
    Huang, Lei
    Lin, Tian
    Zhao, Li-Ying
    Hu, Yan-Feng
    Yu, Jiang
    Cai, Shi-Rong
    Li, Tuanjie
    Li, Guoxin
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (12) : 2065 - 2073
  • [40] Systemic inflammation is associated with the density of immune cells in the tumor microenvironment of gastric cancer
    Choi, Yeonjoo
    Kim, Jin Won
    Nam, Kyung Han
    Han, Song-Hee
    Kim, Ji-Won
    Ahn, Sang-Hoon
    Park, Do Joong
    Lee, Keun-Wook
    Lee, Hye Seung
    Kim, Hyung-Ho
    GASTRIC CANCER, 2017, 20 (04) : 602 - 611